{
  "trial_id": "NCT00780988",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "surgically accessible primary or metastatic site",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Estimated survival of 6 months or greater",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Primary may be in place",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Age 18-70",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Must have an ECOG performance status of 0 or 1",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Must have adequate organ and marrow function. Specifically:",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Absolute neutrophil count (ANC) > 1500/uL",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Platelet count >= 100 x 10^9/L",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Total bilirubin <= 2.0 x the upper limit of normal (ULN)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Alkaline phosphatase, AST, and/or ALT <2.5 x the ULN for patients without evidence of liver metastases; <5 X ULN for patients with documented liver metastases",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Serum creatinine < 2.0 mg/dL",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Hemoglobin > 9 g/dL",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Radiotherapy within 28 days prior to the day of tumor resection (Day 1).",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "No myelosuppressive chemotherapy within 28 days prior to the day of tumor resection",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has metastatic papillary thyroid cancer and has undergone radiotherapy, which is a contraindication for this trial.",
  "_meta": {
    "topic_id": "11",
    "trial_id": "NCT00780988",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}